EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The E3 ubiquitin ligase MARCHF8 restricts HSV-1 infection by inhibiting replication of the viral genome

Yongyan Xia, L Rayburn Nigos, Fernando Villalón-Letelier, Melkamu B Tessema, Andrew G Brooks, Eva Bartok, Rayk Behrendt, Sarah L Londrigan, Patrick C Reading, Rubaiyea Farrukee

Journal of Biological Chemistry · 2025

DOI: 10.1016/j.jbc.2025.110567 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025. Verfasst von Yongyan Xia und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australi…. Hauptthemen laut MEDLINE: Herpesvirus 1, Human, Ubiquitin-Protein Ligases, Virus Replication, Genome, Viral. Die Arbeit nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Department of Health and Ageing, Australian Government, Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Host cell restriction factors are intracellular proteins that target and inhibit virus replication. Membrane-associated RING-CH finger (MARCHF) proteins are a family of intracellular E3-ubiquitin ligases and some, including MARCHF8, have been implicated in restricting the replication of diverse RNA viruses. However, little is currently known as to whether MARCHF proteins mediate antiviral activity against DNA viruses. Herein, we used a doxycycline-inducible overexpression system to demonstrate that human MARCHF1 and MARCHF8 potently restrict productive HSV-1 replication and assessed MARCHF8-mediated restriction of HSV-1 in detail. A functional RING-CH domain and a tyrosine-based motif, located in the N- and C-terminal cytoplasmic tail of MARCHF8, respectively, were required for HSV-1 restriction. For many RNA viruses, MARCHF8-mediated restriction has been associated with downregulation of viral envelope glycoproteins from the cell surface, thereby limiting their subsequent incorporation into nascent virions. However, while MARCHF8 expression did not affect virus entry, translocation of viral genome to the nucleus and immediate early (IE) gene expression, it did inhibit HSV-1 genomic replication, and therefore subsequent late gene expression and release of infectious virions. MARCHF8-mediated restriction of HSV-1 occurred independent of other cellular factors known to impact genomic replication of HSV-1, namely SAMHD1 and CD81, and could also proceed efficiently in cells expressing a functional cGAS-STING pathway. To our knowledge, these studies are the first to demonstrate MARCHF8-mediated restriction against a human DNA virus. Moreover, inhibition of HSV-1 genomic replication represents a novel mechanism of MARCHF8-mediated virus restriction that is distinct to its reported antiviral activity against different RNA viruses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpesvirus 1, HumanUbiquitin-Protein LigasesVirus ReplicationGenome, ViralMembrane ProteinsHerpes SimplexHumansHEK293 CellsChlorocebus aethiopsAnimals

Stichwörter der Autor:innen

E3 ubiquitin ligaseMARCHF8 proteinherpesvirusinnate immunityviral immunologyvirologyvirus restriction

Substanzen

Ubiquitin-Protein LigasesMembrane ProteinsMARCHF8 protein, human

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia.
  • Institute of Experimental Haematology and Transfusion Medicine, University Hospital, University of Bonn, Bonn, Germany.
  • The Institute of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany.
  • Department of Microbiology and Immunology, The University of Melbourne, at the Peter Doherty Institute for Infection and Immunity, Victoria, Australia; WHO Collaborating Centre for Reference and Research on Influenza, V…

Förderung

  • National Health and Medical Research Council
  • Department of Health and Ageing, Australian Government
  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Xia, Y., Nigos, L. R., Villalón-Letelier, F., Tessema, M. B., Brooks, A. G., Bartok, E., Behrendt, R., Londrigan, S. L., Reading, P. C., & Farrukee, R. (2025). The E3 ubiquitin ligase MARCHF8 restricts HSV-1 infection by inhibiting replication of the viral genome. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2025.110567

Vancouver

Xia Y, Nigos LR, Villalón-Letelier F, Tessema MB, Brooks AG, Bartok E, et al. The E3 ubiquitin ligase MARCHF8 restricts HSV-1 infection by inhibiting replication of the viral genome. Journal of Biological Chemistry. 2025. doi:10.1016/j.jbc.2025.110567

BibTeX
@article{Xia2025,
  author = {Xia, Yongyan and Nigos, L Rayburn and Villalón-Letelier, Fernando and Tessema, Melkamu B and Brooks, Andrew G and Bartok, Eva and Behrendt, Rayk and Londrigan, Sarah L and Reading, Patrick C and Farrukee, Rubaiyea},
  title = {The E3 ubiquitin ligase MARCHF8 restricts HSV-1 infection by inhibiting replication of the viral genome},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  doi = {10.1016/j.jbc.2025.110567}
}
Kostenlos starten →